Avinger, Inc (AVGR)

Trade AVGR now with
8/23/2018 8:35:00 AM Avinger Completes Enrollment In SCAN Clinical Study
7/12/2018 8:34:56 AM Avinger Announces Pricing Of $3.55 Mln Registered Direct Offering
7/10/2018 8:32:13 AM Avinger Appoints Jaafer Golzar As Chief Medical Officer
6/14/2018 8:31:33 AM Avinger Says First Patients Enrolled In Post-Market Study Comparing Pantheris OCT Imaging To Intravascular Ultrasound
5/23/2018 8:33:50 AM Avinger Gets 510(k) Clearance From FDA For Next Generation Pantheris Lumivascular Atherectomy System
5/14/2018 4:34:33 PM Avinger Q1 Loss/share $5.37 Vs. Loss $25.74 Year Ago
3/29/2018 9:07:42 AM Avinger Reports First-in-Patient Use Of Extended Nosecone Version Of Next Generation Pantheris
3/19/2018 4:02:47 PM Avinger Q4 Loss/share $12.58 Vs. Loss $23.35 Year Ago
3/2/2018 8:03:56 AM Avinger Regains Compliance With Nasdaq Listing Requirements
2/14/2018 8:31:36 AM Avinger Announces Pricing Of $18 Mln Underwritten Public Offering
3/30/2016 9:57:25 AM Canaccord Reiterates Avinger, Inc (AVGR) At Buy With $20 Price Target